Loading
AI
Achaogen, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by DUGGAN ROBERT W, was filed 12 Dec 2018.
Achaogen, Inc.: what insiders have been doing
Achaogen, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). No insider at Achaogen, Inc. has published a filing in the past twelve months. The most recent one dates from 20 March 2019.
The full history, which starts in 2016, counts 35 purchases against 43 sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
118
Thresholds
n/a
Buy Volume
€34M
35 ops. · all time
Sell Volume
€2M
43 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2018FY ended December 2018 · cache
Income statement
Revenue7.8M
Net income-166.3M-2136.9% margin
Last declaration on 20 March 2019
Declarations118 total
271,879 shares@ US$0.560.6% of flowCommon Stock, par value $0.001 per shareSEC:0000921895-19-000842:0
956,009 shares@ US$0.532.1% of flowCommon Stock, par value $0.001 per shareSEC:0000921895-19-000842:1
50,000 shares@ US$0.530.1% of flowCommon Stock, par value $0.001 per shareSEC:0000921895-19-000842:2
520,102 shares@ US$0.631.3% of flowCommon Stock, par value $0.001 per shareSEC:0000921895-19-000731:0
633,975 shares@ US$0.611.6% of flowCommon Stock, par value $0.001 per shareSEC:0000921895-19-000731:1
1,199,930 shares@ US$0.592.9% of flowCommon Stock, par value $0.001 per shareSEC:0000921895-19-000731:2
1,388 shares@ US$0.89100.0% of flowCommon StockSEC:0001567619-19-005388:0
3,771 shares@ US$0.897.7% of flowCommon StockSEC:0001567619-19-005386:0
971 shares@ US$0.89100.0% of flowCommon StockSEC:0001567619-19-005390:0
1,063 shares@ US$0.8915.2% of flowCommon StockSEC:0001567619-19-005389:0
791 shares@ US$0.898.9% of flowCommon StockSEC:0001567619-19-005387:0
818 shares@ US$1.3517.5% of flowCommon StockSEC:0001567619-19-002682:0
187,800 shares0Common StockSEC:0001567619-19-001517:0
281,700 shares0Common StockSEC:0001567619-19-001515:0
156,500 shares0Common StockSEC:0001567619-19-001516:0
156,500 shares0Common StockSEC:0001567619-19-001518:0
156,500 shares0Common StockSEC:0001567619-19-001519:0
436,500 shares@ US$1.602.2% of flowCommon Stock, par value $0.001 per shareSEC:0000921895-18-003283:0
Canonical exit: 10 Mar 2019 (T+90)
306,848 shares@ US$1.651.6% of flowCommon Stock, par value $0.001 per shareSEC:0000921895-18-003283:1
Canonical exit: 11 Mar 2019 (T+90)
22,431 shares@ US$1.400.1% of flowCommon Stock, par value $0.001 per shareSEC:0000921895-18-003263:0
Canonical exit: 7 Mar 2019 (T+90)
80,175 shares@ US$1.890.5% of flowCommon Stock, par value $0.001 per shareSEC:0000921895-18-003165:0
Canonical exit: 21 Feb 2019 (T+90)
77,585 shares@ US$1.680.4% of flowCommon Stock, par value $0.001 per shareSEC:0000921895-18-003165:1
Canonical exit: 25 Feb 2019 (T+90)
231,495 shares@ US$1.931.4% of flowCommon Stock, par value $0.001 per shareSEC:0001193805-18-001360:0
Canonical exit: 18 Feb 2019 (T+90)
4,648 shares@ US$1.620.0% of flowCommon Stock, par value $0.001 per shareSEC:0000921895-18-003124:0
Canonical exit: 17 Feb 2019 (T+90)
3,242 shares@ US$4.1529.8% of flowCommon StockSEC:0001567619-18-003253:0
25 of 118 declarations
About Achaogen, Inc.
Achaogen, Inc. is a biopharmaceutical company focused on developing treatments for antibiotic-resistant bacterial infections. It is listed on the XNAS market.
